Full Name
Dr. Rachel Nugent
Job Title
Vice President, Global Noncommunicable Diseases
Company (Please input the full name of your organization)
RTI International
Speaking At
Speaker Bio
Rachel Nugent, PhD, has more than 30 years of experience in global development as a researcher, practitioner, and policy advisor to governments. She leads a team charged with providing policy analysis, implementation, and evaluation of cost-effective strategies to prevent and control global noncommunicable diseases (NCDs). RTI’s global NCD experts generate and translate new evidence to help guide global and national decision-making aimed at noncommunicable disease detection, prevention, and control. In an effort to reduce premature mortality from these diseases, Dr. Nugent will coordinate capabilities including health economics and evaluation; communication and behavior change; epidemiology and survey research; establishment of disease and risk factor registries; and development of guidelines, care pathways, and medical technology applications for global NCDs.
Dr. Nugent is a member of the Lancet Commission on Noncommunicable Diseases and Injuries of the Poorest Billion, the U.S. Institute of Medicine Committee on Economic Evaluation, and the International Expert Group for the Global Nutrition Report. She also works with the World Health Organization Global Coordination Mechanism Working Group on Noncommunicable Disease Financing and is on the External Advisory Committee of the NCD Alliance and Children’s Heartlink.
Dr. Nugent's interests include the economic benefits of controlling antimicrobial resistance. She was the lead author and chair of The Race Against Drug Resistance, a 2010 report from the Center for Global Development’s expert working group on global drug resistance. The report produced four high-level recommendations to combat antimicrobial and other forms of drug resistance in diseases especially affecting poor countries, and it has been used extensively by the media and government agencies to guide the development of solutions to the epidemic of drug resistance globally.
Previously, Dr. Nugent was an associate professor of global health at the University of Washington and director and principal investigator of the Disease Control Priorities Network. She previously worked at the Center for Global Development, the Population Reference Bureau, the Fogarty International Center of NIH, and the Food and Agriculture Organization of the United Nations.
Dr. Nugent is a member of the Lancet Commission on Noncommunicable Diseases and Injuries of the Poorest Billion, the U.S. Institute of Medicine Committee on Economic Evaluation, and the International Expert Group for the Global Nutrition Report. She also works with the World Health Organization Global Coordination Mechanism Working Group on Noncommunicable Disease Financing and is on the External Advisory Committee of the NCD Alliance and Children’s Heartlink.
Dr. Nugent's interests include the economic benefits of controlling antimicrobial resistance. She was the lead author and chair of The Race Against Drug Resistance, a 2010 report from the Center for Global Development’s expert working group on global drug resistance. The report produced four high-level recommendations to combat antimicrobial and other forms of drug resistance in diseases especially affecting poor countries, and it has been used extensively by the media and government agencies to guide the development of solutions to the epidemic of drug resistance globally.
Previously, Dr. Nugent was an associate professor of global health at the University of Washington and director and principal investigator of the Disease Control Priorities Network. She previously worked at the Center for Global Development, the Population Reference Bureau, the Fogarty International Center of NIH, and the Food and Agriculture Organization of the United Nations.
LinkedIn
